Clinical Trial Results: Positive clinical trial outcomes for SNGY's drug candidates typically drive the stock price up, while negative results can cause it to fall.

Regulatory Approvals: FDA or other regulatory agency approvals for SNGY's products significantly boost investor confidence and increase stock value.

Partnerships and Collaborations: Agreements with larger pharmaceutical companies or research institutions often lead to higher stock prices due to increased validation and potential revenue streams.

Financial Performance: SNGY's revenue, expenses, and profitability directly impact investor sentiment. Strong financials typically lead to a higher stock price.

Market Sentiment: Overall market conditions, industry trends, and investor confidence in the biotechnology sector can influence SNGY's stock price.

Competition: The success of competing drugs or therapies can negatively impact SNGY's potential market share and stock value.

Intellectual Property: The strength and duration of SNGY's patents and intellectual property rights are crucial for protecting its products and maintaining a competitive advantage, positively affecting the stock price.